Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

1,363 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Completed

Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors

NCT03945773

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • SALK - Salzburger Landesklinik Salzburg, Austria
  • CHRU Besançon Besançon, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Léon Bérard Lyon, France
View all 40 locations
View Trial Details
Completed

Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer

NCT02718066

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations
  • [Site 02] Mayo Clinic Arizona Phoenix, Arizona, United States
  • [Site 11] University of California, San Diego Medical Center La Jolla, California, United States
  • [Site 01] Hematology - Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • [Site 09] H. Lee Moffitt Cancer Center and Research Institute, Inc. Tampa, Florida, United States
View Trial Details
Completed

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

NCT04374877

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +30 more
Locations
  • City of Hope Duarte, California, United States
  • University of Southern California (USC) - Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Miami Leonard M. Miller School of Medicine (UMMSM) Miami, Florida, United States
View all 23 locations
View Trial Details
Completed

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NCT02009449

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +64 more
Locations
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
View Trial Details
Completed

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

NCT04773951

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
Locations
  • Fujian Provincial Cancer Hospital Fuzhou, Fujian, China
  • Tumor Hospital affiliated to Harbin Medical University Harbin, Heilongjiang, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details

Related conditions